Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$33.8K Buy
120
+1
+0.8% +$290 0.01% 194
2025
Q2
$33.3K Sell
119
-25
-17% -$7.08K 0.01% 187
2025
Q1
$44.7K Buy
144
+1
+0.7% +$295 0.02% 160
2024
Q4
$37.2K Sell
143
-148
-51% -$43.9K 0.02% 178
2024
Q3
$93.8K Buy
+291
New +$95.2K 0.04% 99
2024
Q1
$40K Buy
141
+91
+182% +$26.6K 0.02% 172
2023
Q4
$14K Buy
+50
New +$13.6K 0.01% 280
2021
Q1
Sell
-78
Closed -$18K 56
2020
Q4
$18K Buy
+78
New +$18K 0.01% 212
2020
Q3
Sell
-63
Closed -$15K 69
2020
Q2
$15K Buy
63
+15
+31% +$3.42K 0.01% 219
2020
Q1
$10K Hold
48
0.01% 239
2019
Q4
$12K Buy
+48
New +$10.6K 0.01% 283

Other funds holding AMGN

FSA Wealth Management's AMGN Position: Q3 2025 in Review

FSA Wealth Management increased its Amgen (AMGN) stake by 0.84% in Q3 2025, buying an estimated $290 and bringing the position to 120 shares worth $33.8K. The position accounts for 0.01% of the portfolio, ranked #194.

FSA Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 11 quarters since. The position peaked at $93.8K in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • FSA Wealth Management held 120 shares of Amgen worth $33.8K as of Q3 2025.
  • FSA Wealth Management bought 1 Amgen share in Q3 2025, an estimated $290.
  • Amgen made up 0.01% of FSA Wealth Management's portfolio in Q3 2025, its #194 holding.
  • FSA Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 11 quarters since.
  • FSA Wealth Management's Amgen position peaked at $93.8K in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.